Postprandial macrophage-derived IL-1β stimulates insulin, and both synergistically promote glucose disposal and inflammation (original) (raw)

• Dinarello, C.A. Multiple biological properties of recombinant human interleukin 1 (β). Immunobiology 172, 301–315 (1986).
  Article CAS PubMed Google Scholar
• Wellen, K.E. & Hotamisligil, G.S. Inflammation, stress, and diabetes. J. Clin. Invest. 115, 1111–1119 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Hotamisligil, G.S., Shargill, N.S. & Spiegelman, B.M. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259, 87–91 (1993).
  Article CAS PubMed Google Scholar
• Donath, M.Y., Dalmas, É., Sauter, N.S. & Böni-Schnetzler, M. Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity. Cell Metab. 17, 860–872 (2013).
  Article CAS PubMed Google Scholar
• Ehses, J.A., Böni-Schnetzler, M., Faulenbach, M. & Donath, M.Y. Macrophages, cytokines and beta-cell death in Type 2 diabetes. Biochem. Soc. Trans. 36, 340–342 (2008).
  Article CAS PubMed Google Scholar
• Donath, M.Y. & Shoelson, S.E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11, 98–107 (2011).
  Article CAS PubMed Google Scholar
• Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237–241 (2006).
  Article CAS PubMed Google Scholar
• Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357–1361 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Vandanmagsar, B. et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17, 179–188 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Wen, H. et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12, 408–415 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Stienstra, R. et al. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab. 12, 593–605 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Maedler, K. et al. Glucose-induced beta cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. J. Clin. Invest. 110, 851–860 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Masters, S.L. et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat. Immunol. 11, 897–904 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, R., Tardivel, A., Thorens, B., Choi, I. & Tschopp, J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11, 136–140 (2010).
  Article CAS PubMed Google Scholar
• Stienstra, R. et al. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc. Natl. Acad. Sci. USA 108, 15324–15329 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Ehses, J.A. et al. IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc. Natl. Acad. Sci. USA 106, 13998–14003 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Larsen, C.M. et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356, 1517–1526 (2007).
  Article CAS PubMed Google Scholar
• van Asseldonk, E.J. et al. Treatment with Anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study. J. Clin. Endocrinol. Metab. 96, 2119–2126 (2011).
  Article CAS PubMed Google Scholar
• Cavelti-Weder, C. et al. Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes. Diabetes Care 35, 1654–1662 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Hensen, J., Howard, C.P., Walter, V. & Thuren, T. Impact of interleukin-1β antibody (canakinumab) on glycaemic indicators in patients with type 2 diabetes mellitus: results of secondary endpoints from a randomized, placebo-controlled trial. Diabetes Metab. 39, 524–531 (2013).
  Article CAS PubMed Google Scholar
• Sloan-Lancaster, J. et al. Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1β antibody, in patients with type 2 diabetes. Diabetes Care 36, 2239–2246 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Gubser, P.M. et al. Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch. Nat. Immunol. 14, 1064–1072 (2013).
  Article CAS PubMed Google Scholar
• Fox, C.J., Hammerman, P.S. & Thompson, C.B. Fuel feeds function: energy metabolism and the T-cell response. Nat. Rev. Immunol. 5, 844–852 (2005).
  Article CAS PubMed Google Scholar
• Macintyre, A.N. et al. The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. Cell Metab. 20, 61–72 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Freemerman, A.J. et al. Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. J. Biol. Chem. 289, 7884–7896 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Tannahill, G.M. et al. Succinate is an inflammatory signal that induces IL-1(through HIF-1α. Nature 496, 238–242 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Böni-Schnetzler, M. et al. Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I. Endocrinology 150, 5218–5229 (2009).
  Article PubMed CAS Google Scholar
• Benner, C. et al. The transcriptional landscape of mouse beta cells compared to human beta cells reveals notable species differences in long non-coding RNA and protein-coding gene expression. BMC Genomics 15, 620 (2014).
  Article PubMed PubMed Central Google Scholar
• Bendtzen, K. et al. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 232, 1545–1547 (1986).
  Article CAS PubMed Google Scholar
• Mandrup-Poulsen, T. et al. Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans. Diabetologia 29, 63–67 (1986).
  Article CAS PubMed Google Scholar
• Zawalich, W.S. & Zawalich, K.C. Interleukin 1 is a potent stimulator of islet insulin secretion and phosphoinositide hydrolysis. Am. J. Physiol. 256, E19–E24 (1989).
  CAS PubMed Google Scholar
• Donath, M.Y., Böni-Schnetzler, M., Ellingsgaard, H., Halban, P.A. & Ehses, J.A. Cytokine production by islets in health and diabetes: cellular origin, regulation and function. Trends Endocrinol. Metab. 21, 261–267 (2010).
  Article CAS PubMed Google Scholar
• Caumo, A. & Luzi, L. First-phase insulin secretion: does it exist in real life? Considerations on shape and function. Am. J. Physiol. Endocrinol. Metab. 287, E371–E385 (2004).
  Article CAS PubMed Google Scholar
• Baggio, L.L. & Drucker, D.J. Biology of incretins: GLP-1 and GIP. Gastroenterology 132, 2131–2157 (2007).
  Article CAS PubMed Google Scholar
• Van Oostrom, A.J., Sijmonsma, T.P., Rabelink, T.J., Van Asbeck, B.S. & Cabezas, M.C. Postprandial leukocyte increase in healthy subjects. Metabolism 52, 199–202 (2003).
  Article CAS PubMed Google Scholar
• Herieka, M. & Erridge, C. High-fat meal induced postprandial inflammation. Mol. Nutr. Food Res. 58, 136–146 (2014).
  Article CAS PubMed Google Scholar
• Pétrilli, V. et al. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 14, 1583–1589 (2007).
  Article PubMed CAS Google Scholar
• Okabe, Y. & Medzhitov, R. Tissue-specific signals control reversible program of localization and functional polarization of macrophages. Cell 157, 832–844 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Platell, C., Cooper, D., Papadimitriou, J.M. & Hall, J.C. The omentum. World J. Gasteroenterol. 6, 169–176 (2000).
  Google Scholar
• Shrivastava, P. & Bhatia, M. Essential role of monocytes and macrophages in the progression of acute pancreatitis. World J. Gasteroenterol. 16, 3995–4002 (2010).
  Article CAS Google Scholar
• Cani, P.D. et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761–1772 (2007).
  Article CAS PubMed Google Scholar
• Breton, J. et al. Gut commensal E. coli proteins activate host satiety pathways following nutrient-induced bacterial growth. Cell Metab. 23, 324–334 (2016).
  Article CAS PubMed Google Scholar
• Zhang, D. et al. Neutrophil ageing is regulated by the microbiome. Nature 525, 528–532 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Corbett, J.A., Wang, J.L., Sweetland, M.A., Lancaster, J.R. Jr. & McDaniel, M.L. Interleukin 1β induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide. J. Clin. Invest. 90, 2384–2391 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• Hajmrle, C. et al. Interleukin-1 signaling contributes to acute islet compensation. J. Clin. Invest. 1, e86055 (2016).
  Google Scholar
• Greenwood, R.H., Mahler, R.F. & Hales, C.N. Improvement in insulin secretion in diabetes after diazoxide. Lancet 1, 444–447 (1976).
  Article CAS PubMed Google Scholar
• Olefsky, J.M. & Glass, C.K. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 72, 219–246 (2010).
  Article CAS PubMed Google Scholar
• Mauer, J. et al. Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance. PLoS Genet. 6, e1000938 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Costa Rosa, L.F., Safi, D.A., Cury, Y. & Curi, R. The effect of insulin on macrophage metabolism and function. Cell Biochem. Funct. 14, 33–42 (1996).
  Article CAS PubMed Google Scholar
• Zinman, B. et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med. 373, 2117–2128 (2015).
  Article CAS PubMed Google Scholar
• Ravassard, P. et al. A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion. J. Clin. Invest. 121, 3589–3597 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Horai, R. et al. Production of mice deficient in genes for interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 receptor antagonist shows that IL-1β is crucial in turpentine-induced fever development and glucocorticoid secretion. J. Exp. Med. 187, 1463–1475 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Farley, F.W., Soriano, P., Steffen, L.S. & Dymecki, S.M. Widespread recombinase expression using FLPeR (flipper) mice. Genesis 28, 106–110 (2000).
  Article CAS PubMed Google Scholar
• Clausen, B.E., Burkhardt, C., Reith, W., Renkawitz, R. & Förster, I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8, 265–277 (1999).
  Article CAS PubMed Google Scholar
• Preitner, F. et al. Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors. J. Clin. Invest. 113, 635–645 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Wueest, S. et al. Fas (CD95) expression in myeloid cells promotes obesityinduced muscle insulin resistance. EMBO Mol. Med. 6, 43–56 (2014).
  Article CAS PubMed Google Scholar
• Caiazzo, R. et al. Quantitative in vivo islet potency assay in normoglycemic nude mice correlates with primary graft function after clinical transplantation. Transplantation 86, 360–363 (2008).
  Article PubMed Google Scholar